# Find emerging competitors Canonical URL: https://biopharmsignal.com/use-cases/biotech-competitive-intelligence/find-emerging-competitors Role: [Biotech Competitive Intelligence Teams](https://biopharmsignal.com/use-cases/biotech-competitive-intelligence.md) Category: Strategy and business development Last updated: 2026-07-26 Capture new companies and programs before they become obvious peers. ## The Situation New private companies, stealth programs, spinouts, and early clinical assets may become relevant before they appear in standard public-company peer lists. ### Best Fit Competitive intelligence, business development, corporate strategy, clinical, regulatory, and commercial teams inside biotech and pharmaceutical companies. ## The Challenge Capture new companies and programs before they become obvious peers. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. ## How To Think About The Task New private companies, stealth programs, spinouts, and early clinical assets may become relevant before they appear in standard public-company peer lists. For competitive intelligence, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again. Capture new companies and programs before they become obvious peers. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later. ### Start with the decision this work must support “Find emerging competitors” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful. ### Build a source-linked change record The core monitoring set for this workflow includes new company formation, trial registrations, conference abstracts, licensing and financing, leadership and scientific origin. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot. ### Turn monitoring into an owned output An emerging-competitor queue with program identity, evidence, ownership, relevance, source confidence, and next monitoring event. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The team identifies new entrants early enough to update landscapes and strategic assumptions. ## Illustrative Example ### Illustrative workflow: find emerging competitors Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change. Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event. ### Questions To Answer Before Making A Decision - What has changed in new company formation, and why does it matter? - What has changed in trial registrations, and why does it matter? - What has changed in conference abstracts, and why does it matter? - What has changed in licensing and financing, and why does it matter? - What has changed in leadership and scientific origin, and why does it matter? ## A Repeatable Workflow 1. Define the specific decision or research question behind “find emerging competitors.” 2. Set the monitored scope around new company formation and trial registrations. 3. Collect source-linked updates for conference abstracts and record what changed from the prior state. 4. Review licensing and financing together with leadership and scientific origin before drawing a conclusion. 5. Produce the required output, assign follow-up ownership, and set the next review point. ## Signals To Keep Visible - New company formation - Trial registrations - Conference abstracts - Licensing and financing - Leadership and scientific origin ## Common Mistakes - Starting the monitoring process without a defined decision question - Recording the latest state without preserving its source or previous state - Ending with collected information but no owner, conclusion, or next review ## Deliverable An emerging-competitor queue with program identity, evidence, ownership, relevance, source confidence, and next monitoring event. ## Practical Outcome The team identifies new entrants early enough to update landscapes and strategic assumptions. ## Where BioPharmSignal Fits Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep relevant tickers and keywords visible. The workflow still requires independent research and judgment. ## Frequently Asked Questions ### Who is this workflow for? It is designed for biotech competitive intelligence teams and adjacent biotech research users who need a repeatable, source-linked way to complete this task. ### What should this workflow produce? An emerging-competitor queue with program identity, evidence, ownership, relevance, source confidence, and next monitoring event. ### What is the practical benefit? The team identifies new entrants early enough to update landscapes and strategic assumptions. ## Related Workflows - [How Biotech Teams Map a Competitive Target Landscape](https://biopharmsignal.com/use-cases/biotech-competitive-intelligence/map-biotech-target-landscape.md) - [How Biotech Teams Monitor Competitor Clinical Progress](https://biopharmsignal.com/use-cases/biotech-competitive-intelligence/monitor-competitor-clinical-progress.md) - [How Biotech BD Teams Identify Partnership Signals](https://biopharmsignal.com/use-cases/biotech-competitive-intelligence/identify-biotech-partnership-signals.md) Format note: This is an illustrative workflow guide, not a named customer testimonial or a claim of investment performance.